期刊
TOXINS
卷 14, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/toxins14050332
关键词
post stroke spasticity; botulinum toxin type A; higher doses
In recent years, there has been increasing interest in using higher doses of botulinum toxin type A for severe spasticity in the upper and lower limbs. While one study has investigated the safety and tolerability of using a dose of up to 800 U, there is limited evidence on the reasons for using high doses of botulinum toxin. This short communication highlights the benefits of higher doses for individuals with upper and lower limb spasticity.
In the past few years, there was a great interest in the use of higher doses of botulinum toxin type A, especially in case of upper and lower limb severe spasticity. To date, only one prospective, non-randomized, single-arm, multicenter, open-label, dose-titration study with the employment of incobotulinum toxin up to 800 U has been published, and the authors investigated safety and tolerability. Other researches showed efficacy in spasticity reduction, but there is a lack of evidence about the reasons to use high doses of botulinum toxin. This short communication highlights the benefits of higher doses for subjects with upper and lower limb spasticity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据